RE:RE:RE:If they split, Apparo will die, Viemed will thriveI agree, it's a no brainier to chose the organic growth with the higher margin. But keep in mind that in the 18 months before Crawford sold Patient Aids he completed five acquisitions. If can continue to find deals like the one in April at 1-1/2 times ebitda then he'll have no problem growing fast and profitably. Like most low margin businesses size and scale are what will make you successful. If Apparo is making a small profit with almost 100m in revenue think how hard it is on the smaller businesses doing 5m or so in revenue that he'll be trying to buy....